Literature DB >> 1548751

Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.

K A Stellrecht1, K Sperber, B G Pogo.   

Abstract

A variety of DNA viruses are known to activate gene expression directed by the long terminal repeat (LTR) of human immunodeficiency virus type 1 (HIV-1). In light of the proposed use of recombinant vaccinia virus for HIV-1 vaccines, evaluation of the role of vaccinia virus in HIV-1 activation is warranted. To investigate whether vaccinia virus induces HIV LTR-directed gene expression, transient expression assays in Jurkat cells persistently infected with vaccinia virus (Jvac) using plasmid DNA containing the LTR linked to the bacterial chloramphenicol acetyltransferase (CAT) gene were performed. CAT activity in Jvac cells was always recorded, although the level appears to fluctuate independently of virus titers. Dual intracytoplasmic staining and fluorescence-activated cell sorter analysis showed that CAT activity was expressed in the infected cells. CAT expression was not due to plasmid replication, since plasmid DNA extracted from Jvac cells 48 h after transfection was restricted only by enzymes which recognize methylated sequences, indicating a prokaryotic source for the DNA. These findings suggest that a factor(s) present in vaccinia virus-infected cells is capable of activating the LTR of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548751      PMCID: PMC288995     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 2.  The molecular pathogenesis of poxviruses.

Authors:  P C Turner; R W Moyer
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

Authors:  M Siekevitz; S F Josephs; M Dukovich; N Peffer; F Wong-Staal; W C Greene
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

5.  The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes.

Authors:  M A Albrecht; N A DeLuca; R A Byrn; P A Schaffer; S M Hammer
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

Review 6.  Vaccinia virus: a tool for research and vaccine development.

Authors:  B Moss
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

7.  Hepatitis B virus X gene can transactivate heterologous viral sequences.

Authors:  J S Twu; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors.

Authors:  E Seto; P J Mitchell; T S Yen
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

9.  Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.

Authors:  E Seto; T S Yen; B M Peterlin; J H Ou
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein.

Authors:  G J Kotwal; A W Hügin; B Moss
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

View more
  5 in total

1.  Are worry-free transfusions just a whiff of ozone away?

Authors:  A C Baggs
Journal:  CMAJ       Date:  1993-04-01       Impact factor: 8.262

2.  Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.

Authors:  M A Subler; D W Martin; S Deb
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

3.  IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).

Authors:  G Ferrari; K King; K Rathbun; C A Place; M V Packard; J A Bartlett; D P Bolognesi; K J Weinhold
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

4.  The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus.

Authors:  F M Jault; S A Spector; D H Spector
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  Impairment of monocytic function after influenza virus infection.

Authors:  M Louie; J Yoo; T Moran; L Mayer; K Sperber
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.